Nature Communications (Jun 2021)

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions

  • Malina A. Bakowski,
  • Nathan Beutler,
  • Karen C. Wolff,
  • Melanie G. Kirkpatrick,
  • Emily Chen,
  • Tu-Trinh H. Nguyen,
  • Laura Riva,
  • Namir Shaabani,
  • Mara Parren,
  • James Ricketts,
  • Anil K. Gupta,
  • Kastin Pan,
  • Peiting Kuo,
  • MacKenzie Fuller,
  • Elijah Garcia,
  • John R. Teijaro,
  • Linlin Yang,
  • Debashis Sahoo,
  • Victor Chi,
  • Edward Huang,
  • Natalia Vargas,
  • Amanda J. Roberts,
  • Soumita Das,
  • Pradipta Ghosh,
  • Ashley K. Woods,
  • Sean B. Joseph,
  • Mitchell V. Hull,
  • Peter G. Schultz,
  • Dennis R. Burton,
  • Arnab K. Chatterjee,
  • Case W. McNamara,
  • Thomas F. Rogers

DOI
https://doi.org/10.1038/s41467-021-23328-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 14

Abstract

Read online

Here, the authors perform repurposing screens of the ReFRAME drug library in two cell lines and identify inhibitors of SARS-CoV-2 infection. Antiviral activity of prodrug MK-4482 is confirmed in hamsters.